Thirty Years On: What the 1996 HRV Task Force Report Still Teaches HRV Biofeedback Trainers
Updated: Sep 8
In 1996, a joint Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology published the document that still anchors the field of heart rate variability (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology [Task Force], 1996). It standardized the vocabulary, fixed the recording durations, named the metrics worth reporting, and warned about the ones that invite overreach.
Thirty years later, clinicians and human performance professionals train clients with finger sensors, chest straps, and phone apps that the authors never imagined. The physiology has not changed, and neither have most of the pitfalls.
This post pulls out the lessons that matter most for heart rate variability (HRV) biofeedback practice and checks each one against the research that has followed.
Why a Cardiology Consensus Statement Belongs on a Biofeedback Practitioner's Desk
The Task Force formed because HRV had become easy to measure and easy to misread. Commercial devices offered automated numbers, and the authors worried about incorrect conclusions and unfounded extrapolations (Task Force, 1996). They set five goals: standardize terms, specify measurement methods, define physiological correlates, describe appropriate clinical uses, and identify research needs. Members came from mathematics, engineering, physiology, and clinical medicine. That mix explains why the document reads as both a measurement manual and a physiology primer.
HRV reflects the moment-to-moment influence of the autonomic nervous system on the sinus node, the heart's natural pacemaker. The autonomic nervous system is the branch of the nervous system that regulates heart rate and other involuntary functions through its sympathetic and parasympathetic divisions.
The Task Force treated HRV as a window onto that regulation, not as a health score. It also reminded readers that HRV earned its clinical standing as a mortality predictor after myocardial infarction (Kleiger et al., 1987; Task Force, 1996). That history should shape how confidently we speak about it.
The same problem confronts HRV biofeedback today at a larger scale. Wearables now generate HRV scores for millions of people, and the interpretive gap between a number on a screen and what it means has widened rather than closed (Damoun et al., 2024; Sammito et al., 2024).
A practitioner who understands the 1996 standards can explain to a client why two devices disagree, why a morning reading differs from a session reading, and why a single metric rarely tells the whole story. That explanatory skill is part of what clients pay for.
Lesson One: Recording Length Decides What You Can Compare
The Task Force made a point that many practitioners still overlook. Total variance grows with recording length, so the standard deviation of NN intervals (SDNN) is not a well-defined quantity unless the duration is fixed (Task Force, 1996). An NN interval is the time between adjacent normal heartbeats that originate in the sinus node.
Comparing the SDNN from a 2-minute session with the SDNN from a 24-hour recording is comparing two different measurements that share a name. The authors settled on two standard durations: 5-minute short-term recordings under stable conditions and nominal 24-hour long-term recordings.
They also derived a rule for how long a recording must be to capture a given rhythm. A recording should last at least ten times the wavelength of the slowest rhythm of interest (Task Force, 1996).
The report translated that rule into about 1 minute for the high-frequency band and about 2 minutes for the low-frequency band. Ten full cycles at the 0.04 Hz lower edge of the low-frequency band take 250 seconds, which is another reason the 5-minute window has persisted.
For 24-hour time domain analysis, the authors asked for at least 18 hours of usable data that include the whole night, because day-night differences contribute a large share of long-term variability.
Ultra-short-term research has tested how far these limits can bend. In 3,387 resting adults, 10-second recordings reproduced 5-minute RMSSD and 30-second recordings reproduced 5-minute SDNN (Munoz et al., 2015).
A UK Biobank analysis found that RMSSD from 15-second electrocardiograms correlated 0.84 with 6-minute values and predicted later cardiovascular events (Orini et al., 2023). A 2026 study found that 30-second statistical measures and HF power matched 5-minute values only in rested, alert participants, and that mental fatigue or drowsiness required longer windows (Maciejewska et al., 2026).
A critical review of this literature argued that each ultra-short-term HRV metric must be validated against its 5-minute criterion, and that few metrics pass strict tests at windows under 1 minute (Shaffer et al., 2020).
For practitioners, the lesson is practical. Fix the length of your baseline recordings and keep it identical across sessions and clients. If you use 1-minute or 2-minute snapshots during training, treat them as within-session trend data rather than as values to compare against published 5-minute norms. Label every reported value with its recording length so that colleagues can interpret it correctly.
Lesson Two: Four Time Domain Metrics Earn Their Keep
The Task Force recommended four time domain measures because many others correlate so closely that they add little. SDNN estimates overall HRV. The HRV triangular index estimates overall HRV from the shape of the NN interval histogram and tolerates casual editing. The SDANN, the standard deviation of 5-minute average NN intervals, estimates long-term components. The RMSSD, the root mean square of successive differences, estimates short-term vagally mediated variability (Task Force, 1996).
The authors preferred the RMSSD to the pNN50 and NN50 because it has better statistical properties (Task Force, 1996). Later methodological reviews reached the same conclusion for a different reason.
The RMSSD tracks vagal modulation, meaning modulation carried by the vagus nerve, while resisting the respiratory rate effects that distort spectral high-frequency power (Hill & Siebenbrock, 2009; Laborde et al., 2017). RMSSD has therefore become the default metric in sports science and consumer wearables. That popularity brings its own hazards, which Lesson Five addresses.
The report also supplied the first widely used cut-offs. After myocardial infarction, a 24-hour SDNN below 50 ms or a triangular index below 15 marked highly depressed HRV, and SDNN below 100 ms marked moderately depressed HRV (Task Force, 1996). These thresholds came from cardiac patients on 24-hour recordings.
Applying them to a healthy client's 5-minute baseline is a category error. The report's own table of normal values carried a warning that some entries came from small samples and that no definite clinical conclusion should rest on them (Task Force, 1996).
Thirty years of normative work has not closed that gap. Short-term norms exist, and they vary widely across studies, ages, sexes, and methods (Nunan et al., 2010; Shaffer & Ginsberg, 2017; Tegegne et al., 2020).
A 2025 systematic review identified 58 reference-value studies published between 1989 and 2022, with samples ranging from 20 to 84,772 people and recordings ranging from seconds to 24 hours (Brozat et al., 2025). The authors concluded that no generally accepted reference values exist. A norm is only useful when its population, duration, sensor, and conditions match the person in front of you.
Report the SDNN and RMSSD from every baseline and note the recording length beside each. Compare a client's values only against norms collected with the same duration, posture, and breathing instructions. When you cannot find a matched norm, compare the client to themselves. Session-to-session change under identical conditions is the most defensible comparison a practitioner can make.
Lesson Three: Spectral Bands Measure Modulation, Not Tone
Power spectral density (PSD) analysis divides HRV into rhythms by frequency. The Task Force defined three components in short-term recordings. Very-low-frequency (VLF) power lies below 0.04 Hz, low-frequency (LF) power spans 0.04 to 0.15 Hz, and high-frequency (HF) power spans 0.15 to 0.4 Hz (Task Force, 1996). A fourth ultra-low-frequency (ULF) power component appears only in 24-hour recordings. The authors called VLF from 5-minute segments a dubious measure that analysts should avoid interpreting.
They assigned HF power to efferent vagal activity, based on vagal stimulation, muscarinic blockade, and vagotomy studies. They were candid that LF power was contested, with some investigators reading it as sympathetic modulation and others as a mix of sympathetic and vagal influence (Task Force, 1996).
The report also insisted that normalized units, which express LF and HF as proportions of total power minus VLF, should always accompany absolute values in milliseconds squared. Normalization can make LF appear to rise during tilt when absolute LF actually fell, because total power dropped.
The most consequential sentence in this section is easy to skim past. HRV measures the degree of autonomic modulation, meaning the size of the fluctuations in autonomic input to the heart, not the average level of autonomic tone (Malik & Camm, 1993; Task Force, 1996).
Both autonomic withdrawal and a saturating sympathetic drive reduce HRV. A low value therefore cannot tell you by itself which branch is responsible. This distinction separates careful interpretation from guesswork.
Subsequent research settled the LF debate largely against the sympathetic reading. In patients with and without cardiac sympathetic denervation, supine LF power tracked baroreflex function rather than cardiac noradrenergic innervation (Goldstein et al., 2011). The baroreflex is the pressure-sensing reflex that adjusts heart rate to stabilize blood pressure.
A reanalysis of pharmacological and orthostatic studies concluded that LF mainly reflects baroreflex modulation of both autonomic branches (Reyes del Paso et al., 2013).
Billman (2013) showed that the LF/HF ratio can rise when blockade silences both branches and can fall during exercise, and concluded that it does not measure sympathovagal balance.
The 2026 cardiovascular guidelines adopt this position outright. They state that HRV has value for risk stratification but should not serve as a marker of cardiac sympathetic outflow or sympathovagal balance. They also caution against reading respiratory modulation as a clean index of vagal tone (Carter et al., 2026).
For HRV biofeedback, this lesson carries a specific consequence. Breathing near 6 breaths per minute moves the respiratory heart rate rhythm into the LF band, so LF power and the LF/HF ratio rise during training for reasons that have nothing to do with sympathetic activation.
A pharmacological blockade study made the point directly. When six healthy young adults breathed at 4 to 9 breaths per minute, blocking parasympathetic transmission nearly abolished the power at the breathing frequency, whereas sympathetic blockade left it largely unchanged (Kromenacker et al., 2018). The LF peak during slow breathing is vagal.
Do not tell clients that resonance breathing raises their sympathetic activity, and do not use LF/HF as a training target. Describe the rise in LF power as evidence of baroreflex engagement, which is what the training is designed to produce (Lehrer & Gevirtz, 2014). Hayano and Yuda (2019) cataloged these and related pitfalls for anyone who uses HRV as an autonomic index.
Lesson Four: Respiration Writes the Spectrum
The Task Force listed controlled respiration among the manipulations that increase HF power (Task Force, 1996). It also noted that respiratory rate correlated with HF even in some transplanted hearts, which hinted at a mechanical contribution to respiratory sinus arrhythmia (RSA), the heart rate rhythm that rises with inhalation and falls with exhalation.
The authors further warned that spectral results only make sense under stationarity, the condition in which the mechanisms driving heart period stay stable across the recording. A client who breathes at 15 breaths per minute during one baseline and 8 during the next has changed the experiment.
Later methodological guidelines made respiration an explicit reporting requirement. Laborde et al. (2017) recommended measuring or controlling respiration rate, adjusting HF band limits for populations that breathe unusually fast or slowly, and pairing spectral values with RMSSD as a cross-check.
A meta-analysis confirmed that voluntary slow breathing increases HRV both acutely and after training. In a controlled comparison, paced breathing at 6 cycles per minute raised the RMSSD whether or not participants also saw biofeedback (Laborde et al., 2022).
Ritz (2024) added that breathing depth as well as rate changes the size of respiratory heart rate oscillations without necessarily changing the underlying vagal influence. Larger breaths make larger waves.
The mechanism explains why the effect is so large. Breathing near each person's resonance frequency, usually between 4.5 and 6.5 breaths per minute, drives heart rate and blood pressure oscillations that the baroreflex amplifies (Lehrer & Gevirtz, 2014; Vaschillo et al., 2006).
The stepped protocol identifies that frequency by having the client breathe at several rates for a few minutes each (Lehrer et al., 2000; Shaffer & Meehan, 2020).
The practitioner watches heart rate oscillation amplitude and cardiorespiratory coherence, the degree to which heart rate and breathing rise and fall together. Training at the resonance frequency produces the largest heart rate oscillations a person can generate.
The adaptation outlasts the session. In 54 healthy adults, ten biofeedback sessions raised baroreflex gain, the size of the heart rate response to a given blood pressure change, both during practice and at rest (Lehrer et al., 2003). The increase in resting gain did not depend on respiratory changes. That finding supports a real physiological adaptation, although the healthy sample and untrained control group limit what it says about treating disease.
Whether each client needs an individually determined frequency remains an open question. A four-week randomized trial assigned 88 adults with elevated stress to individualized resonance frequency training, fixed 0.1 Hz training, or a waitlist (Sumińska et al., 2026). Both training groups reduced stress, anxiety, and depressive symptoms relative to the waitlist, with no meaningful difference between them, and neither group changed resting HRV.
The trial was retrospectively registered and was not powered to prove equivalence. Individual assessment remains reasonable practice, but a fixed 6 breaths per minute is a defensible fallback when assessment is impractical.
Slow breathing can also become overbreathing. Hyperventilation means moving more air than metabolism requires, which lowers carbon dioxide, and large slow breaths can produce it.
In a randomized comparison, an instruction to avoid excessively deep breaths reduced the drop in end-tidal carbon dioxide during 0.1 Hz breathing (Szulczewski, 2019). End-tidal carbon dioxide is the carbon dioxide measured at the end of exhalation, and the same instruction reduced hyperventilation symptoms.
Coach gentle, unforced breaths, and if a client reports lightheadedness or tingling, shorten the breath rather than the rate.
Record respiration during every baseline, even if only from a strap or a visual count. Instruct clients to breathe normally during baselines and never to practice slow breathing during a baseline that you plan to compare across sessions.
When a client's resting HF power or RMSSD rises after weeks of training, check whether their resting breathing rate also fell. A lower resting rate is a legitimate training effect, but it changes what the spectral values mean.
Lesson Five: Clean Signals or No Signals
The report devoted more space to signal quality than to any single metric. It asked for a sampling rate of 250 to 500 Hz, or at least 100 Hz with parabolic interpolation to refine the R-wave fiducial point (Task Force, 1996). The sampling rate is the number of measurements per second a device takes from the electrocardiogram, and the fiducial point is the reference mark used to time each heartbeat.
The report demanded a well-tested QRS detection algorithm and warned that filters could distort the low-frequency end of the spectrum. Above all, it required manual editing of every RR interval to a very high standard whenever analysts use statistical or spectral methods.
The authors were blunt about automatic correction. Filters that exclude intervals differing by more than 20 percent from the previous one should not replace manual editing, because they behave unsatisfactorily and create errors of their own (Task Force, 1996).
Casual editing suffices only for geometric methods. The report also asked researchers to publish the number and duration of intervals that they omitted or interpolated. Transparency about editing was part of the standard, not an afterthought.
Later studies quantified the damage. Berntson and Stowell (1998) showed that a single missed or extra beat can inflate short-term variability far beyond any plausible physiological change. In 178 participants, inserting one artifact into a 4-minute recording raised the RMSSD by 413 percent supine and 269 percent standing, while LF and HF shifted by less than 10 percent (Bourdillon et al., 2022). An artifact is any spurious interval that does not reflect a true sinus beat.
An ectopic beat, a heartbeat that originates outside the sinus node, does the same damage even though it is a real cardiac event. The RMSSD became significantly biased when artifacts exceeded 0.9 percent of the signal (Bourdillon et al., 2022).
Automatic correction is not a safe substitute.
Threshold-based correction changed HRV values across three human cohorts, and the strongest settings interpolated up to 39 percent of the data in children (Alcantara et al., 2020).
The choice of correction method also altered results during exercise, with error growing at higher intensities (Giles & Draper, 2018). Peltola (2012) reviewed editing strategies and concluded that the editing method itself can change conclusions.
Sampling rate findings have largely confirmed the 1996 guidance. Down-sampling from 1,000 Hz to 250 Hz preserved excellent agreement, 100 Hz remained acceptable for time-domain measures but not spectral measures, and 50 Hz failed both (Kwon et al., 2018).
A separate analysis recommended at least 125 Hz with R-peak interpolation for short-term measures (Ellis et al., 2015). Current psychophysiology publication guidelines go further and recommend 1,000 Hz when it is feasible (Quigley et al., 2024).
Beat detection itself deserves scrutiny. A widely used correction algorithm detected 97 percent of real ectopic beats with a specificity of 99.9 percent in its validation set (Lipponen & Tarvainen, 2019). That is excellent performance for one algorithm on one dataset, not a guarantee for every device.
When researchers ran eight QRS detectors on recordings from 25 adults at rest, under cognitive load, and during physical activity, agreement with manually annotated HRV ranged from near perfect to near zero (Weinstein et al., 2026). The result depended on the detector and on the recording setup.
The Task Force also defined NN intervals as sinus-node beats, so a client in atrial fibrillation, a rhythm with disorganized atrial activity, produces interval variability that conventional HRV analysis cannot interpret (Task Force, 1996). Refer uncertain rhythms for medical review before you train on them.
The report never considered optical sensors, yet its logic applies directly to them. Photoplethysmography (PPG) measures pulse arrival at the finger or wrist with light, so it yields pulse rate variability (PRV) rather than HRV.
Pulse transit time varies beat to beat with vascular tone, adding variability that the heart never produced (Yuda et al., 2020). A 2026 meta-analysis of 43 studies found pooled standardized errors of 0.19 for the RMSSD and 0.13 for the SDNN between PPG and electrocardiography, with agreement depending on sensor site, sampling rate, and posture (Xu et al., 2026).
A direct comparison of an arm-worn optical sensor and a chest strap found that agreement varied with position, duration, sex, and age (Coste et al., 2025).
Use electrocardiography or a validated chest strap for any baseline you intend to interpret. Inspect the interbeat interval plot before you trust a number, and correct or discard segments rather than letting the software decide silently. If you must use a finger or wrist sensor, keep the client still, record longer, and note the values as PRV. Reserve wearable scores for trend tracking and never for diagnosis.
Lesson Six: Know What Counts as Real Change
The Task Force reviewed reproducibility and reached a reassuring conclusion for long recordings and a cautionary one for short ones. Short-term HRV returns to baseline quickly after mild perturbations such as light exercise or short-acting vasodilators, but maximal exercise or long-acting drugs delay recovery (Task Force, 1996).
Twenty-four-hour measures showed high stability in healthy people and cardiac patients over months and even years. The authors described 24-hour indices as stable and free of placebo effect, and therefore ideal for evaluating interventions.
They also acknowledged how little anyone knew about environmental effects during long recordings. Physical activity, emotional circumstances, and posture all shape HRV, and the report asked investigators to describe recording conditions and to match them across subjects (Task Force, 1996). It further asked investigators to acknowledge differences in underlying heart rate when comparing groups. A slower heart usually produces larger interval variability, so interpret heart rate and HRV together.
de Geus et al. (2019) reviewed this relationship and advised reporting both mean heart period and HRV rather than mechanically correcting one for the other, because a blanket correction can erase real physiology.
Recent reviews have expanded that list of confounders considerably. Age, sex, genetics, fitness, alcohol, smoking, medications, time of day, temperature, noise, posture, and recording duration all move HRV (Damoun et al., 2024; Sammito et al., 2024).
Sports scientists have learned that daily RMSSD readings in athletes fluctuate too much for single values to guide decisions, and that rolling weekly averages of log-transformed RMSSD track training adaptation better (Plews et al., 2013). Those weekly averages are the practical descendant of the Task Force's 24-hour stability finding.
Establish a multi-session baseline before you judge progress. Record at the same time of day, in the same posture, after the same caffeine and exercise abstention, and note any medication change. Ask about sleep and alcohol the night before each session. A change in the RMSSD that you cannot distinguish from day-to-day noise is not a training effect, and a client deserves to know the difference.
Lesson Seven: HRV Is a Marker, Not the Target
The section on modifying HRV contains the report's sharpest warning, and it speaks directly to biofeedback. Because low HRV predicted mortality after infarction, investigators reasoned that raising HRV should protect the heart.
The authors called that rationale sound but flagged the inherent danger of assuming that changing the marker changes the outcome (Task Force, 1996). HRV, they wrote, is just a marker of autonomic activity, and the real target is cardiac electrical stability. Nobody knew how much vagal activity must increase to confer protection.
The evidence they reviewed showed why the caution mattered. Beta-blockers raised HRV only modestly in patients. Low-dose scopolamine raised HRV substantially but did not prevent ventricular fibrillation during ischemia in post-infarction dogs (Hull et al., 1995; Task Force, 1996).
Exercise training, by contrast, raised the SDNN by 74 percent in high-risk dogs, and every trained animal survived a new ischemic challenge (Hull et al., 1994). The intervention that changed both the marker and the outcome also changed the underlying physiology.
The Task Force accepted only two clinical uses of HRV in adults. Depressed HRV predicts risk after acute myocardial infarction, and it provides an early warning of diabetic autonomic neuropathy (Task Force, 1996). Everything else, including hypertension, heart failure, and neurological disease, remained a research application. That restraint contrasts with the sweeping claims that now accompany HRV in wellness marketing.
HRV biofeedback has since accumulated outcome evidence that the Task Force never had. Meta-analyses have found a large between-group effect on self-reported stress and anxiety across 24 studies (Goessl et al., 2017) and a medium effect on depressive symptoms across 14 randomized trials (Pizzoli et al., 2021).
A broader review reported small to medium effects on anxiety, depression, anger, and athletic and artistic performance (Lehrer et al., 2020). A 2026 meta-analysis of 18 remote or hybrid trials found medium effects on depression and on HRV itself, and no significant effect on perceived stress (Vann-Adibe et al., 2026). HRV gains were larger when clients maximized resonance in real time and practiced 20 minutes or less per day.
Sham-controlled trials now separate the skill from its effects. In 47 healthy adults, active biofeedback improved depressive symptoms and affect more than a credible sham control, a treatment mimic that withholds the active ingredient (Minjoz et al., 2026). The authors concluded that HRV change may not be the main mechanism of benefit.
In 53 healthy older adults, five weeks of active and sham training both improved sleep and resting HRV (Allen et al., 2026). The groups did not differ in resting HRV, emotional functioning, or cognition, and the only group-specific effect appeared during stress recovery.
The pattern repeats elsewhere. A brief resonance breathing exercise in 135 young adults with high worry raised HRV during practice but did not improve inhibitory control or worry relative to an active breathing comparison (Spalding et al., 2025). Sumińska et al. (2026) likewise found symptom improvement without any change in resting HRV. Training HRV, resting HRV, and symptoms can move independently.
The cardiovascular signal is encouraging but early.
A pilot randomized trial in 21 adults with coronary artery disease found that six weeks of biofeedback increased myocardial flow reserve during mental stress compared with usual care (Shah et al., 2025). That is a physiological outcome, not fewer infarctions, and the authors called for a larger trial.
Adherence is the quieter problem. In a fully remote program for 127 healthcare workers, only 16.5 percent completed at least half of the prescribed five-minute daily sessions, and the psychological changes were not significant (Hirten et al., 2024).
These findings support HRV biofeedback as a treatment for specific symptoms, and practitioners should present it that way. Name the outcomes you are targeting, such as anxiety or depressive symptoms, and measure them directly.
Report HRV change as evidence that the client learned the skill, not as proof that their health improved. Measure learning, persistence, and benefit as three separate questions, because a client can master the breathing without a lasting rise in resting HRV and can improve emotionally without one. Expect smaller heart rate oscillation gains in older clients, because biofeedback amplitude declines with age (Aschbacher et al., 2024).
Lesson Eight: The Report Knew What It Did Not Know
The Task Force devoted a section to nonlinear methods and declined to endorse any of them. The authors judged that no breakthrough had yet come from applying complexity measures to HRV, that standards were lacking, and that these tools were not ready for clinical studies (Task Force, 1996).
They flagged PP and PR interval variability, multi-signal analysis, and transient HRV dynamics as unfinished business. They also called for large prospective studies to establish normal values across age and sex. That candor is part of why the document has aged well.
A 2015 joint position statement from two European cardiology bodies reviewed newer time-frequency, nonlinear, and complexity methods (Sassi et al., 2015). It concluded that most still lack the validation needed for routine clinical use.
Reviews of HRV metrics and norms now describe Poincaré plot measures, entropy indices, and detrended fluctuation analysis alongside the classic measures (Shaffer & Ginsberg, 2017). A Poincaré plot graphs each NN interval against the next one, and its width and length summarize short-term and long-term variability. Large cohorts have produced reference values for 10-second recordings stratified by age and sex (Tegegne et al., 2020).
The healthy heart, as one review put it, is not a metronome, and the nonlinear measures try to capture the complexity behind that observation (Shaffer et al., 2014). Treat the nonlinear indices on your display as exploratory. Report the SD1 and SD2 from the Poincaré plot if your software provides them, but recognize that the SD1 mathematically mirrors RMSSD (Shaffer & Ginsberg, 2017).
Do not build training targets around entropy or fractal measures until validation studies exist in your client population. Keep classic time- and frequency-domain measures as the backbone of your assessments.
Putting the Lessons to Work in the Clinic
A practitioner can translate these lessons into a repeatable assessment routine. Begin every training session with a 5-minute seated baseline recorded by electrocardiography or a validated chest strap, with the client breathing at their natural pace and respiration recorded. Inspect and edit the interbeat intervals before computing anything. Report mean heart rate, breathing rate, the SDNN, the RMSSD, and absolute LF and HF power, and write the recording length next to each value.
Next, determine the resonance frequency with a stepped protocol, and record the result along with the metrics that guided the choice (Shaffer & Meehan, 2020). Train at that frequency and monitor LF power, heart rate oscillation amplitude, and coherence during practice, but keep those training-phase values separate from baseline values in your records. Repeat the standardized baseline at fixed intervals under matched conditions. Track symptom measures alongside HRV so that you can show clients both what they learned and what changed.
Write down how you chose the breathing rate, what feedback the client saw, how much practice actually occurred, and what outcome changed. A systematic review of 143 biofeedback studies found that protocol details were often too incomplete to replicate (Lalanza et al., 2023), and a clinical record can do better than the literature.
Finally, choose your language with the same care the Task Force applied. Say modulation rather than tone. Say baroreflex engagement rather than sympathetic activation when LF rises during slow breathing. Say pulse rate variability when the sensor is optical. Small wording changes protect clients from conclusionsthe data cannot support.
Integrative Summary
The 1996 Task Force Report endures because it treated HRV as a measurement problem before it treated it as a biomarker. Its authors fixed recording durations, chose a handful of metrics, defined spectral bands, demanded clean signals, and refused to promise more than the evidence allowed. Three decades of research have refined those positions rather than overturned them.
Ultra-short-term recordings work under narrow conditions, LF power belongs to the baroreflex, a single artifact can quadruple RMSSD, optical sensors measure a related but different quantity, and HRV biofeedback now has sham-controlled trials of its own. Those trials show that symptoms can improve without resting HRV changing, which is exactly the marker-versus-outcome distinction the Task Force drew in 1996. Practitioners who absorb these lessons measure more carefully, interpret more modestly, and serve their clients better.
Five Key Takeaways
1. Fix your recording length and never compare HRV values across different durations. A 5-minute seated baseline remains the standard for short-term assessment.
2. Report the SDNN and RMSSD from every baseline, compare clients against duration-matched norms or against themselves, and treat post-infarction cut-offs as inapplicable to healthy clients.
3. HRV indexes autonomic modulation, not tone. LF power reflects baroreflex activity, so the LF/HF ratio should not serve as a measure of sympathovagal balance or as a training target.
4. Signal quality determines validity. Use electrocardiography or a validated chest strap at 250 Hz or higher, inspect and edit every interbeat interval, and label optical sensor data as pulse rate variability.
5. HRV is a marker rather than the target. Present HRV biofeedback as a treatment for measured symptoms, report HRV change as skill acquisition, and remember that sham-controlled trials show symptoms can improve without resting HRV changing.
Glossary
artifact: any spurious interbeat interval, such as a missed, extra, or ectopic beat, that does not reflect a true sinus-node heartbeat.
atrial fibrillation: a rhythm with disorganized atrial electrical activity whose irregular ventricular timing conventional HRV analysis cannot interpret.
autonomic modulation: the size of the moment-to-moment fluctuations in sympathetic and parasympathetic input to the heart, as distinct from the average level of that input.
autonomic nervous system: the branch of the nervous system that regulates heart rate and other involuntary functions through its sympathetic and parasympathetic divisions.
baroreflex: the pressure-sensing reflex in which arterial baroreceptors adjust heart rate and vascular tone to stabilize blood pressure.
baroreflex gain: the size of the heart rate or heart period response produced by a given change in blood pressure, a measure of baroreflex sensitivity.
cardiorespiratory coherence: the degree to which heart rate and breathing rise and fall together at a single dominant frequency.
down-sampling: reducing the sampling rate of a recorded signal by discarding or averaging samples, for example converting a 1,000 Hz ECG to 250 Hz. In HRV work it matters because a lower rate widens the timing uncertainty of each R-wave peak, which adds jitter to the interbeat intervals and inflates or distorts short-term measures such as the RMSSD and HF power.
ectopic beat: a heartbeat that originates outside the sinus node; it is a real cardiac event but is excluded from NN interval analysis.
end-tidal carbon dioxide: the carbon dioxide concentration measured at the end of exhalation, used to detect overbreathing.
fiducial point: the reference mark on each electrocardiogram complex, usually the R-wave peak, used to time successive heartbeats.
heart rate variability (HRV): the fluctuation in the time intervals between consecutive heartbeats.
high frequency (HF) power: spectral power between 0.15 and 0.4 Hz, largely produced by vagally mediated respiratory sinus arrhythmia.
HRV triangular index: the total number of NN intervals divided by the height of the NN interval histogram, an estimate of overall 24-hour HRV.
hyperventilation: breathing that moves more air than metabolism requires, which lowers carbon dioxide and can occur even at slow rates if breaths are large.
LF/HF ratio: low frequency power divided by high frequency power, once proposed as an index of sympathovagal balance and no longer supported as one.
low-frequency (LF) power: spectral power between 0.04 and 0.15 Hz, mainly reflecting baroreflex modulation of both autonomic branches.
NN interval: the time between two adjacent normal heartbeats that originate in the sinus node, after artifacts and ectopic beats have been removed.
normalized units: LF or HF power expressed as a proportion of total power minus VLF power, reported alongside absolute values.
photoplethysmography (PPG): an optical technique that detects blood volume pulses at the finger, wrist, or ear using reflected or transmitted light.
pNN50: the percentage of adjacent NN intervals that differ by more than 50 ms.
Poincaré plot: a scatter plot of each NN interval against the next one, whose width (SD1) and length (SD2) summarize short-term and long-term variability.
power spectral density (PSD): a mathematical description of how HRV variance distributes across frequencies.
pulse rate variability (PRV): the variability in intervals between successive pulse waves measured by photoplethysmography, which differs from HRV because pulse transit time varies beat to beat.
resonance frequency: the breathing rate, usually between 4.5 and 6.5 breaths per minute, at which heart rate oscillations reach their maximum amplitude.
respiratory sinus arrhythmia (RSA): the rhythm in which heart rate rises during inhalation and falls during exhalation.
RMSSD: the root mean square of successive differences between adjacent NN intervals, an index of short-term vagally mediated HRV.
sampling rate: the number of measurements per second a device takes from the electrocardiogram or pulse signal, expressed in hertz.
SDANN: the standard deviation of the average NN intervals calculated over 5-minute segments of a long recording, an estimate of long-term HRV components.
sham control: a comparison condition that mimics the treatment procedure while withholding its intended active component.
standard deviation of NN intervals (SDNN): the standard deviation of all NN intervals in a recording, an estimate of overall HRV whose value depends on recording length.
stationarity: the condition in which the physiological mechanisms driving heart period remain stable across the whole recording.
sympathovagal balance: the proposed relationship between sympathetic and parasympathetic activity that the LF/HF ratio was once thought to index.
ultra-low-frequency (ULF) power: spectral power below 0.003 Hz, measurable only in 24-hour recordings and associated with circadian and slow regulatory rhythms.
ultra-short-term HRV: HRV computed from recordings shorter than the 5-minute short-term standard, typically 10 seconds to 4 minutes.
vagal: relating to the vagus nerve, the main parasympathetic pathway that slows heart rate.
very-low-frequency (VLF) power: spectral power below 0.04 Hz, whose physiological origin remains uncertain and which the Task Force advised against interpreting in 5-minute recordings.
References
Alcantara, J. M. A., Plaza-Florido, A., Amaro-Gahete, F. J., Acosta, F. M., Migueles, J. H., Molina-Garcia, P., Sacha, J., Sanchez-Delgado, G., & Martinez-Tellez, B. (2020). Impact of using different levels of threshold-based artefact correction on the quantification of heart rate variability in three independent human cohorts. Journal of Clinical Medicine, 9(2), 325. https://doi.org/10.3390/jcm9020325
Allen, W. D., Talbert, L. D., Wheeler, A., Hartwell, B., Jensen, T., Young, E., Baldwin, T., Olpin, K., Baldwin, S. A., Steffen, P. R., & Larson, M. J. (2026). A randomized sham-controlled study of heart rate variability biofeedback in an older adult sample. Applied Psychophysiology and Biofeedback. Advance online publication. https://doi.org/10.1007/s10484-026-09803-8
Aschbacher, K., Mather, M., Lehrer, P., Gevirtz, R., Epel, E., & Peiper, N. C. (2024). Real-time heart rate variability biofeedback amplitude during a large-scale digital mental health intervention differed by age, gender, and mental and physical health. Psychophysiology, 61, e14533. https://doi.org/10.1111/psyp.14533
Berntson, G. G., & Stowell, J. R. (1998). ECG artifacts and heart period variability: Don't miss a beat! Psychophysiology, 35(1), 127–132. https://doi.org/10.1111/1469-8986.3510127
Billman, G. E. (2013). The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Frontiers in Physiology, 4, 26. https://doi.org/10.3389/fphys.2013.00026
Bourdillon, N., Yazdani, S., Vesin, J.-M., Schmitt, L., & Millet, G. P. (2022). RMSSD is more sensitive to artifacts than frequency-domain parameters: Implication in athletes' monitoring. Journal of Sports Science and Medicine, 21(2), 260–266. https://doi.org/10.52082/jssm.2022.260
Brozat, M., Böckelmann, I., & Sammito, S. (2025). Systematic review on HRV reference values. Journal of Cardiovascular Development and Disease, 12(6), 214. https://doi.org/10.3390/jcdd12060214
Carter, J. R., Jenkins, N. D. M., Bigalke, J. A., Robinson, A. T., Keller-Ross, M. L., Greaney, J. L., Fonkoue, I. T., Fadel, P. J., Macefield, V. G., Charkoudian, N., Levine, B. D., & Joyner, M. J. (2026). Guidelines for rigor and reproducibility of heart rate variability within human cardiovascular research. American Journal of Physiology-Heart and Circulatory Physiology, 331(3), H918–H943. https://doi.org/10.1152/ajpheart.00041.2026
Coste, A., Millour, G., & Hausswirth, C. (2025). A comparative study between ECG- and PPG-based heart rate sensors for heart rate variability measurements: Influence of body position, duration, sex, and age. Sensors, 25(18), 5745. https://doi.org/10.3390/s25185745
Damoun, N., Amekran, Y., Taiek, N., & El Hangouche, A. J. (2024). Heart rate variability measurement and influencing factors: Towards the standardization of methodology. Global Cardiology Science and Practice, 2024(4), e202435. https://doi.org/10.21542/gcsp.2024.35
de Geus, E. J. C., Gianaros, P. J., Brindle, R. C., Jennings, J. R., & Berntson, G. G. (2019). Should heart rate variability be "corrected" for heart rate? Biological, quantitative, and interpretive considerations. Psychophysiology, 56(2), e13287. https://doi.org/10.1111/psyp.13287
Ellis, R. J., Zhu, B., Koenig, J., Thayer, J. F., & Wang, Y. (2015). A careful look at ECG sampling frequency and R-peak interpolation on short-term measures of heart rate variability. Physiological Measurement, 36(9), 1827–1852. https://doi.org/10.1088/0967-3334/36/9/1827
Giles, D. A., & Draper, N. (2018). Heart rate variability during exercise: A comparison of artefact correction methods. Journal of Strength and Conditioning Research, 32(3), 726–735. https://doi.org/10.1519/JSC.0000000000001800
Goessl, V. C., Curtiss, J. E., & Hofmann, S. G. (2017). The effect of heart rate variability biofeedback training on stress and anxiety: A meta-analysis. Psychological Medicine, 47(15), 2578–2586. https://doi.org/10.1017/S0033291717001003
Goldstein, D. S., Bentho, O., Park, M.-Y., & Sharabi, Y. (2011). Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Experimental Physiology, 96(12), 1255–1261. https://doi.org/10.1113/expphysiol.2010.056259
Hayano, J., & Yuda, E. (2019). Pitfalls of assessment of autonomic function by heart rate variability. Journal of Physiological Anthropology, 38, 3. https://doi.org/10.1186/s40101-019-0193-2
Hill, L. K., & Siebenbrock, A. (2009). Are all measures created equal? Heart rate variability and respiration. Biomedical Sciences Instrumentation, 45, 71–76.
Hirten, R. P., Danieletto, M., Landell, K., Zweig, M., Golden, E., Pyzik, R., Kaur, S., Chang, H., Helmus, D., Sands, B. E., Charney, D., Nadkarni, G., Bagiella, E., Keefer, L., & Fayad, Z. A. (2024). Remote short sessions of heart rate variability biofeedback monitored with wearable technology: Open-label prospective feasibility study. JMIR Mental Health, 11, e55552. https://doi.org/10.2196/55552
Hull, S. S., Jr., Vanoli, E., Adamson, P. B., De Ferrari, G. M., Foreman, R. D., & Schwartz, P. J. (1995). Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation, 91(10), 2516–2519. https://doi.org/10.1161/01.CIR.91.10.2516
Hull, S. S., Jr., Vanoli, E., Adamson, P. B., Verrier, R. L., Foreman, R. D., & Schwartz, P. J. (1994). Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation, 89(2), 548–552. https://doi.org/10.1161/01.CIR.89.2.548
Kleiger, R. E., Miller, J. P., Bigger, J. T., Jr., & Moss, A. J. (1987). Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology, 59(4), 256–262. https://doi.org/10.1016/0002-9149(87)90795-8
Kromenacker, B. W., Sanova, A. A., Marcus, F. I., Allen, J. J. B., & Lane, R. D. (2018). Vagal mediation of low-frequency heart rate variability during slow yogic breathing. Psychosomatic Medicine, 80(6), 581–587. https://doi.org/10.1097/PSY.0000000000000603
Kwon, O., Jeong, J., Kim, H. B., Kwon, I. H., Park, S. Y., Kim, J. E., & Choi, Y. (2018). Electrocardiogram sampling frequency range acceptable for heart rate variability analysis. Healthcare Informatics Research, 24(3), 198–206. https://doi.org/10.4258/hir.2018.24.3.198
Laborde, S., Allen, M. S., Borges, U., Dosseville, F., Hosang, T. J., Iskra, M., Mosley, E., Salvotti, C., Spolverato, L., Zammit, N., & Javelle, F. (2022). Effects of voluntary slow breathing on heart rate and heart rate variability: A systematic review and a meta-analysis. Neuroscience & Biobehavioral Reviews, 138, 104711. https://doi.org/10.1016/j.neubiorev.2022.104711
Laborde, S., Allen, M. S., Borges, U., Iskra, M., Zammit, N., You, M., Hosang, T., Mosley, E., & Dosseville, F. (2022). Psychophysiological effects of slow-paced breathing at six cycles per minute with or without heart rate variability biofeedback. Psychophysiology, 59(1), e13952. https://doi.org/10.1111/psyp.13952
Laborde, S., Mosley, E., & Thayer, J. F. (2017). Heart rate variability and cardiac vagal tone in psychophysiological research: Recommendations for experiment planning, data analysis, and data reporting. Frontiers in Psychology, 8, 213. https://doi.org/10.3389/fpsyg.2017.00213
Lalanza, J. F., Lorente, S., Bullich, R., García, C., Losilla, J.-M., & Capdevila, L. (2023). Methods for heart rate variability biofeedback (HRVB): A systematic review and guidelines. Applied Psychophysiology and Biofeedback, 48(3), 275–297. https://doi.org/10.1007/s10484-023-09582-6
Lehrer, P., & Gevirtz, R. (2014). Heart rate variability biofeedback: How and why does it work? Frontiers in Psychology, 5, 756. https://doi.org/10.3389/fpsyg.2014.00756
Lehrer, P., Kaur, K., Sharma, A., Shah, K., Huseby, R., Bhavsar, J., Sgobba, P., & Zhang, Y. (2020). Heart rate variability biofeedback improves emotional and physical health and performance: A systematic review and meta analysis. Applied Psychophysiology and Biofeedback, 45(3), 109–129. https://doi.org/10.1007/s10484-020-09466-z
Lehrer, P. M., Vaschillo, E., & Vaschillo, B. (2000). Resonant frequency biofeedback training to increase cardiac variability: Rationale and manual for training. Applied Psychophysiology and Biofeedback, 25(3), 177–191. https://doi.org/10.1023/A:1009554825745
Lehrer, P. M., Vaschillo, E., Vaschillo, B., Lu, S.-E., Eckberg, D. L., Edelberg, R., Shih, W. J., Lin, Y., Kuusela, T. A., Tahvanainen, K. U. O., & Hamer, R. M. (2003). Heart rate variability biofeedback increases baroreflex gain and peak expiratory flow. Psychosomatic Medicine, 65(5), 796–805. https://doi.org/10.1097/01.PSY.0000089200.81962.19
Lipponen, J. A., & Tarvainen, M. P. (2019). A robust algorithm for heart rate variability time series artefact correction using novel beat classification. Journal of Medical Engineering & Technology, 43(3), 173–181. https://doi.org/10.1080/03091902.2019.1640306
Maciejewska, K., Zając, C., Duch, K., Giza, M., & Masternak, A. (2026). Validation of the ultra short term heart rate variability measures under changing psychophysiological state of the healthy participants at rest. Scientific Reports, 16, 25609. https://doi.org/10.1038/s41598-026-55797-y
Malik, M., & Camm, A. J. (1993). Components of heart rate variability: What they really mean and what we really measure. American Journal of Cardiology, 72(11), 821–822. https://doi.org/10.1016/0002-9149(93)91070-X
Minjoz, S., Jeanne, R., Pellissier, S., & Hot, P. (2026). Psychophysiological effects of heart rate variability biofeedback versus sham biofeedback: A randomized controlled trial. Biological Psychology, 206, 109254. https://doi.org/10.1016/j.biopsycho.2026.109254
Munoz, M. L., van Roon, A., Riese, H., Thio, C., Oostenbroek, E., Westrik, I., de Geus, E. J. C., Gansevoort, R., Lefrandt, J., Nolte, I. M., & Snieder, H. (2015). Validity of (ultra-)short recordings for heart rate variability measurements. PLOS ONE, 10(9), e0138921. https://doi.org/10.1371/journal.pone.0138921
Nunan, D., Sandercock, G. R. H., & Brodie, D. A. (2010). A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing and Clinical Electrophysiology, 33(11), 1407–1417. https://doi.org/10.1111/j.1540-8159.2010.02841.x
Orini, M., van Duijvenboden, S., Young, W. J., Ramírez, J., Jones, A. R., Hughes, A. D., Tinker, A., Munroe, P. B., & Lambiase, P. D. (2023). Long-term association of ultra-short heart rate variability with cardiovascular events. Scientific Reports, 13, 18966. https://doi.org/10.1038/s41598-023-45988-2
Peltola, M. A. (2012). Role of editing of R-R intervals in the analysis of heart rate variability. Frontiers in Physiology, 3, 148. https://doi.org/10.3389/fphys.2012.00148
Pizzoli, S. F. M., Marzorati, C., Gatti, D., Monzani, D., Mazzocco, K., & Pravettoni, G. (2021). A meta-analysis on heart rate variability biofeedback and depressive symptoms. Scientific Reports, 11, 6650. https://doi.org/10.1038/s41598-021-86149-7
Plews, D. J., Laursen, P. B., Stanley, J., Kilding, A. E., & Buchheit, M. (2013). Training adaptation and heart rate variability in elite endurance athletes: Opening the door to effective monitoring. Sports Medicine, 43(9), 773–781. https://doi.org/10.1007/s40279-013-0071-8
Quigley, K. S., Gianaros, P. J., Norman, G. J., Jennings, J. R., Berntson, G. G., & de Geus, E. J. C. (2024). Publication guidelines for human heart rate and heart rate variability studies in psychophysiology, Part 1: Physiological underpinnings and foundations of measurement. Psychophysiology, 61(9), e14604. https://doi.org/10.1111/psyp.14604
Reyes del Paso, G. A., Langewitz, W., Mulder, L. J. M., van Roon, A., & Duschek, S. (2013). The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: A review with emphasis on a reanalysis of previous studies. Psychophysiology, 50(5), 477–487. https://doi.org/10.1111/psyp.12027
Ritz, T. (2024). Putting back respiration into respiratory sinus arrhythmia or high-frequency heart rate variability: Implications for interpretation, respiratory rhythmicity, and health. Biological Psychology, 185, 108728. https://doi.org/10.1016/j.biopsycho.2023.108728
Sammito, S., Thielmann, B., & Böckelmann, I. (2024). Update: Factors influencing heart rate variability, a narrative review. Frontiers in Physiology, 15, 1430458. https://doi.org/10.3389/fphys.2024.1430458
Sassi, R., Cerutti, S., Lombardi, F., Malik, M., Huikuri, H. V., Peng, C.-K., Schmidt, G., Yamamoto, Y., Gorenek, B., Lip, G. Y. H., Grassi, G., Kudaiberdieva, G., Fisher, J. P., Zabel, M., & Macfadyen, R. (2015). Advances in heart rate variability signal analysis: Joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Europace, 17(9), 1341–1353. https://doi.org/10.1093/europace/euv015
Shaffer, F., & Ginsberg, J. P. (2017). An overview of heart rate variability metrics and norms. Frontiers in Public Health, 5, 258. https://doi.org/10.3389/fpubh.2017.00258
Shaffer, F., McCraty, R., & Zerr, C. L. (2014). A healthy heart is not a metronome: An integrative review of the heart's anatomy and heart rate variability. Frontiers in Psychology, 5, 1040. https://doi.org/10.3389/fpsyg.2014.01040
Shaffer, F., & Meehan, Z. M. (2020). A practical guide to resonance frequency assessment for heart rate variability biofeedback. Frontiers in Neuroscience, 14, 570400. https://doi.org/10.3389/fnins.2020.570400
Shaffer, F., Meehan, Z. M., & Zerr, C. L. (2020). A critical review of ultra-short-term heart rate variability norms research. Frontiers in Neuroscience, 14, 594880. https://doi.org/10.3389/fnins.2020.594880
Shah, A. J., Raggi, P., She, H., Quyyumi, A. A., Levantsevych, O., Johnson, M., Schmidt, K., Garcia, E., Piccinelli, M., Abdulbaki, R., Abdelhadi, N., Kaseer, B., Ginsberg, J. P., Vaccarino, V., & Bremner, J. D. (2025). Heart rate variability biofeedback and mental stress myocardial flow reserve: A randomized clinical trial. JAMA Network Open, 8(10), e2538416. https://doi.org/10.1001/jamanetworkopen.2025.38416
Spalding, D. M., Ejoor, T., Zhao, X., Bomarsi, D., Ciliberti, M., Ottaviani, C., Valášek, M., Hirsch, C., Critchley, H. D., & Meeten, F. (2025). Effects of a brief resonance frequency breathing exercise on heart rate variability and inhibitory control in the context of generalised anxiety disorder. Applied Psychophysiology and Biofeedback, 50(2), 213–233. https://doi.org/10.1007/s10484-025-09687-0
Sumińska, S., Rynkiewicz, A., & Szulczewski, M. (2026). Resonance frequency versus fixed 0.1 Hz breathing in HRV biofeedback: A four-week randomized comparison. Scientific Reports, 16, 22630. https://doi.org/10.1038/s41598-026-53333-6
Szulczewski, M. T. (2019). An anti-hyperventilation instruction decreases the drop in end-tidal CO2 and symptoms of hyperventilation during breathing at 0.1 Hz. Applied Psychophysiology and Biofeedback, 44(3), 247–256. https://doi.org/10.1007/s10484-019-09438-y
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation, 93(5), 1043–1065. https://doi.org/10.1161/01.CIR.93.5.1043
Tegegne, B. S., Man, T., van Roon, A. M., Snieder, H., & Riese, H. (2020). Reference values of heart rate variability from 10-second resting electrocardiograms: The Lifelines Cohort Study. European Journal of Preventive Cardiology, 27(19), 2191–2194. https://doi.org/10.1177/2047487319872567
Vann-Adibe, S., Tsui, H. K. H., Zhou, H. Q., Ciren, Z., Li, C., & Cha, S. K. W. (2026). Efficacy and methodology of remote heart rate variability biofeedback interventions for mental health: A systematic review and meta-analysis. Applied Psychophysiology and Biofeedback, 51(3), 441–452. https://doi.org/10.1007/s10484-025-09750-w
Vaschillo, E. G., Vaschillo, B., & Lehrer, P. M. (2006). Characteristics of resonance in heart rate variability stimulated by biofeedback. Applied Psychophysiology and Biofeedback, 31(2), 129–142. https://doi.org/10.1007/s10484-006-9009-3
Weinstein, A., Rodiño, J., & Otero, M. (2026). Effects of electrocardiogram QRS detection algorithms in heart rate variability metrics. Scientific Reports, 16, 18589. https://doi.org/10.1038/s41598-026-49215-6
Xu, S., Liu, H., Liu, Z., Su, P., & Gu, Z. (2026). Accuracy of photoplethysmography-derived pulse rate variability compared with electrocardiography-derived heart rate variability: A systematic review and meta-analysis. Sensors, 26(16), 5192. https://doi.org/10.3390/s26165192
Yuda, E., Shibata, M., Ogata, Y., Ueda, N., Yambe, T., Yoshizawa, M., & Hayano, J. (2020). Pulse rate variability: A new biomarker, not a surrogate for heart rate variability. Journal of Physiological Anthropology, 39, 21. https://doi.org/10.1186/s40101-020-00233-x
About the Author
Fred Shaffer earned his PhD in Psychology from Oklahoma State University. He earned BCIA certifications in Biofeedback and HRV Biofeedback. Fred is an Allen Fellow and Professor of Psychology at Truman State University, where he has taught for 50 years. He is a Biological Psychologist who consults and lectures in heart rate variability biofeedback, Physiological Psychology, and Psychopharmacology. Fred helped to edit Evidence-Based Practice in Biofeedback and Neurofeedback (3rd and 4th eds.) and helps to maintain BCIA's certification programs. He is a recipient of AAPB's Distinguished Scientist Award and BFE's Lifetime Impact Award.
Support Our Friends
Comments